Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Adatanserin Hcl
2. Wy-50324 Hcl
3. 144966-96-1
4. Adatanserin Hydrochloride [usan]
5. Wy 50324 Hcl
6. Wy-50324-hcl
7. 48bx75b06d
8. N-(2-(4-(2-pyrimidinyl)-1-piperazinyl)ethyl)-1-adamantanecarboxamide Monohydrochloride
9. Adatanserin Hydrochloride (usan)
10. Tricyclo(3.3.1.1(sup 3,7))decane-1-carboxamide, N-(2-(4-(2-pyrimidinyl)-1-piperazinyl)ethyl)-, Monohydrochloride
11. Unii-48bx75b06d
12. Schembl120908
13. Way-seb-324
14. Chembl2107510
15. Dtxsid60162855
16. Seb-324
17. Bdbm50544115
18. D02767
19. Q27259136
20. N-[2-(4-pyrimidin-2-ylpiperazin-1-yl)ethyl]adamantane-1-carboxamide;hydrochloride
| Molecular Weight | 406.0 g/mol |
|---|---|
| Molecular Formula | C21H32ClN5O |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 405.2295384 g/mol |
| Monoisotopic Mass | 405.2295384 g/mol |
| Topological Polar Surface Area | 61.4 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 497 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Wy 50324 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Wy 50324, including repackagers and relabelers. The FDA regulates Wy 50324 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Wy 50324 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Wy 50324 supplier is an individual or a company that provides Wy 50324 active pharmaceutical ingredient (API) or Wy 50324 finished formulations upon request. The Wy 50324 suppliers may include Wy 50324 API manufacturers, exporters, distributors and traders.
click here to find a list of Wy 50324 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Wy 50324 DMF (Drug Master File) is a document detailing the whole manufacturing process of Wy 50324 active pharmaceutical ingredient (API) in detail. Different forms of Wy 50324 DMFs exist exist since differing nations have different regulations, such as Wy 50324 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Wy 50324 DMF submitted to regulatory agencies in the US is known as a USDMF. Wy 50324 USDMF includes data on Wy 50324's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Wy 50324 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Wy 50324 suppliers with USDMF on PharmaCompass.
Wy 50324 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Wy 50324 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Wy 50324 GMP manufacturer or Wy 50324 GMP API supplier for your needs.
A Wy 50324 CoA (Certificate of Analysis) is a formal document that attests to Wy 50324's compliance with Wy 50324 specifications and serves as a tool for batch-level quality control.
Wy 50324 CoA mostly includes findings from lab analyses of a specific batch. For each Wy 50324 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Wy 50324 may be tested according to a variety of international standards, such as European Pharmacopoeia (Wy 50324 EP), Wy 50324 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Wy 50324 USP).
LOOKING FOR A SUPPLIER?
